NCT05999747View on ClinicalTrials.gov

A Study to Find Out if ASP5354 Can Clearly Help Show the Ureter During Surgery in People With or Without Kidney Disease

PHASE3RecruitingINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

March 19, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Intraoperative Ureter VisualizationAbdominolpelvic Surgery
Interventions
DRUG

pudexacianinium chloride

Intravenous

Trial Locations (11)

19140

RECRUITING

Temple University Hospital, Philadelphia

27705

RECRUITING

Duke University Hospital, Durham

28374

RECRUITING

Firsthealth of the Carolinas INC, Pinehurst

33331

RECRUITING

Cleveland Clinic Florida, Weston

33606

RECRUITING

University of South Florida, Tampa

63110

RECRUITING

Washington University Center, St Louis

77030

RECRUITING

Baylor College of Medicine, Houston

RECRUITING

Houston Methodist Hospital, Houston

89102

RECRUITING

University of Nevada, Las Vegas, Las Vegas

92663

RECRUITING

Hoag Memorial Hospital Presbyterian, Newport Beach

98101

RECRUITING

Benaroya Research Institute at VA Mason, Seattle

All Listed Sponsors
lead

Astellas Pharma Global Development, Inc.

INDUSTRY

NCT05999747 - A Study to Find Out if ASP5354 Can Clearly Help Show the Ureter During Surgery in People With or Without Kidney Disease | Biotech Hunter | Biotech Hunter